1. Home
  2. LBGJ vs GBIO Comparison

LBGJ vs GBIO Comparison

Compare LBGJ & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBGJ
  • GBIO
  • Stock Information
  • Founded
  • LBGJ 2007
  • GBIO 2016
  • Country
  • LBGJ China
  • GBIO United States
  • Employees
  • LBGJ N/A
  • GBIO N/A
  • Industry
  • LBGJ
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LBGJ
  • GBIO Health Care
  • Exchange
  • LBGJ NYSE
  • GBIO Nasdaq
  • Market Cap
  • LBGJ 24.7M
  • GBIO 29.2M
  • IPO Year
  • LBGJ 2024
  • GBIO 2020
  • Fundamental
  • Price
  • LBGJ $1.60
  • GBIO $0.44
  • Analyst Decision
  • LBGJ
  • GBIO Strong Buy
  • Analyst Count
  • LBGJ 0
  • GBIO 4
  • Target Price
  • LBGJ N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • LBGJ 71.0K
  • GBIO 497.7K
  • Earning Date
  • LBGJ 06-17-2025
  • GBIO 05-07-2025
  • Dividend Yield
  • LBGJ N/A
  • GBIO N/A
  • EPS Growth
  • LBGJ N/A
  • GBIO N/A
  • EPS
  • LBGJ N/A
  • GBIO N/A
  • Revenue
  • LBGJ $10,794,015.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • LBGJ N/A
  • GBIO N/A
  • Revenue Next Year
  • LBGJ N/A
  • GBIO N/A
  • P/E Ratio
  • LBGJ N/A
  • GBIO N/A
  • Revenue Growth
  • LBGJ N/A
  • GBIO 146.47
  • 52 Week Low
  • LBGJ $1.02
  • GBIO $0.32
  • 52 Week High
  • LBGJ $5.50
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • LBGJ N/A
  • GBIO 59.15
  • Support Level
  • LBGJ N/A
  • GBIO $0.36
  • Resistance Level
  • LBGJ N/A
  • GBIO $0.42
  • Average True Range (ATR)
  • LBGJ 0.00
  • GBIO 0.03
  • MACD
  • LBGJ 0.00
  • GBIO 0.01
  • Stochastic Oscillator
  • LBGJ 0.00
  • GBIO 92.71

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: